The aim was to develop a method for quantification of hepatobiliary uptake and secretion of conjugated bile acids using PET and the 11 C-labeled conjugated bile acid analog [N-methyl-11 C]cholylsarcosine ( 11 C-CSar). Methods: Six pigs (13 experiments) underwent dynamic 11 CCSar PET of the liver with measurements of hepatic blood perfusion and 11 C-CSar concentrations in arterial, portal and hepatic venous blood. In three pigs (seven experiments) bile was collected from a catheter in the common hepatic duct (CHD). PET data were analyzed by a two-tissue compartmental model with calculation of rate constants for transport of 11 C-CSar between blood, hepatocytes and intra-and extra-hepatic bile ducts. PET results were validated against invasive blood and bile measurements. Results: Directly measured secretion rate of 11 C-CSar into bile was equal to removal rate from blood at steady state.
INTRODUCTION
Conjugated bile acids, the major constituents of bile, are essential for efficient intestinal absorption of dietary lipids including lipophilic vitamins and drugs (1) (2) (3) . The major part of the bile acid pool in humans circulates enterohepatically and hepatic de novo synthesis constitutes only about 5% of bile acid secretion (1) (2) (3) . Hepatocellular uptake of conjugated bile acids from sinusoidal blood is primarily mediated by the Na + -taurocholate co-transporting polypeptide (NTCP, SLC10A1) and canalicular secretion from hepatocytes into bile by the bile salt export pump (BSEP, ABCB11) (3) (4) (5) (6) . BSEP is impaired in several cholestatic disorders such as progressive familial intrahepatic cholestasis type 2 (PFIC-2), drug induced cholestasis, primary biliary cholangitis and primary sclerosing cholangitis, conditions that all may lead to accumulation of toxic levels of bile acids in the hepatocytes (3) (4) (5) (6) . It remains, however, difficult to study hepatobiliary uptake and secretion of bile acids in vivo. Isotopically labeled bile acids have been used to study bile uptake and secretion in the isolated perfused rat liver (7, 8) and conscious dog (9) and sandwich-cultures have been used in attempts to predict in vivo kinetics of bile acid turnover (10-12). Clinically used methods such as 99m Tcmebrofenin single-photon emission computed tomography (13) and novel positron emission tomography (PET) tracers for hepatic drug transporters (14) assess different aspects of hepatic excretory function but not specific bile acids transporters.
The radio-labeled conjugated bile acid analog [N-methyl- 11 C]cholylsarcosine ( 11 C-CSar) is a novel tracer for PET of hepatobiliary secretion (15) . Proof-of-concept studies in pigs validated that 11 C-CSar is secreted into bile and circulates enterohepatically without being metabolized which simplifies analysis of PET data by lowering the number of compartments (14,16). The purpose of the present pig study was to determine in vivo hepatobiliary secretion kinetics of 11 C-CSar using dynamic PET of the liver with quantification of individual transport steps and bile flow. The findings were validated against invasive blood and bile measurements.
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MATERIALS AND METHODS

Experimental Set-up
Six anaesthetized pigs (3-4 month old female, Danish Landrace and Yorkshire crossbreed, body weight 39-42 kg) underwent 1-3 successive PET experiments (in total 13 experiments) with 11 C-CSar administered as a continuous intravenous infusion initiated by a priming bolus.
At least six radioactive half-lives (i.e. 2 hours) were allowed to pass between successive 11 CCSar administrations. During PET recordings, blood was collected from a femoral artery, the portal vein, and a hepatic vein for measurements of blood concentrations of 11 C-CSar.
Hepatic blood flow was measured continuously and in three pigs (seven experiments), bile was collected for measurement of bile flow rate and concentration of 11 C-CSar.
The study was approved by the Danish Animal Experiments Inspectorate and performed according to the Danish Animal Experimentation Act and European convention for the protection of vertebrate animals used for experimental and other purposes.
Animal Preparation
The animal was sedated with an intramuscular injection of midazolam and s-ketamine, anesthetized using an infusion of midazolam, s-ketamine and propofol, mechanically ventilated, and kept physiologically stable (17) .
For intravenous infusions, Avanti catheters (Cordis, Denmark) were inserted in the femoral veins. For blood sampling, an Avanti catheter was placed in a femoral artery and a Cournand 6F catheter (Cook, Denmark) in a hepatic vein via the right jugular vein. The liver was accessed through a 30-cm long subcostal incision below the right curvature and a 5.3F catheter (Cook, Denmark) was inserted directly into the portal vein for blood sampling.
Ultrasound transit-time flow meter probes (VeriQ, Medistim, Norway) were placed around the portal vein and hepatic arteries for continuous recording of blood flow rates. In three of the pigs, a modified Silkolatex Kehr T-tube catheter (Willy Rusch GmbH, Germany) was placed directly in the common hepatic duct (CHD) for collection of bile.
Total hepatic blood flow rate, F blood (mL blood/min) was calculated as F HA + F PV , where F HA is the hepatic arterial blood flow rate (mL blood/min) and F PV is the blood flow rate in the portal vein (mL blood/min). F blood deviated less than 5% from the mean value during each PET experiment and individual mean values of F blood were used.
by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from After the last experiment, the pig was given an overdose of phenobarbital (4 g) and the liver was removed and weighed. The liver volume, V liver (mL liver tissue), was calculated using a liver density of 1.07 g/mL liver tissue (18) and used to calculate hepatic blood perfusion, Q (mL blood/min/mL liver tissue), as F blood /V liver .
PET Recordings
The pig was placed in supine position in a Biograph 64 Truepoint PET/CT camera (Siemens Using fused PET/CT-images, regions-of-interest (ROIs) were drawn in adjacent slices in liver tissue with exclusion of large blood vessels and bile ducts and with a distance of at least 3 cm to the gall bladder. The ROIs were summed to a volume-of-interest (liver-VOI) from which the time course of liver tissue concentration of 11 C-CSar, C liver (t) (kBq/mL liver tissue), was generated.
Blood and Bile Samples
During the PET recording, 0.5 mL blood samples were collected at time points 12 x 5 sec, 6
x 10 sec, 6 x 30 sec, 5 x 1 min, 5 x 10 min from the femoral artery, portal vein, and hepatic vein for measurements of blood concentrations of 11 C-CSar (Packard well-counter, CT).
Measurements were corrected for radioactive decay back to the start of the PET recording and time courses of the blood concentrations of 11 C-CSar (kBq/mL blood) in the hepatic artery, C HA (t) (identical to that measured in the femoral artery), portal vein, C PV (t), and hepatic by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from vein, C out (t) were generated. The time course of the flow-weighted mixed inlet concentration of 11 C-CSar to the liver, C in (t) (kBq/mL blood), was calculated as (19) 
where f HA is the arterial flow fraction calculated as F HA /F blood ; it was on average 0.26 (range, 0.18-0.39) with no systematic changes during the experiments.
Bile was collected by letting bile flow continuously from the CHD catheter into test tubes that were weighed before and after sampling. Bile flow rate, F bile (mL bile/min), calculated using a measured bile density of 1.0 g/mL bile, deviated less than 5% from the mean value during each experiment and individual mean values were used. Measured bile concentrations of 11 CCSar (kBq/mL bile) were corrected for radioactive decay back to start of the PET recording and a sampling delay of 6 min yielding time courses of bile concentration of 11 C-CSar, C bile (t).
Calculations from PET Measurements
PET data were analyzed by fitting the kinetic model of hepatobiliary uptake and secretion explained in Figure 1 to data. For this model, we have
Eq. 2c
The model parameters Kmem, kbackflux, kBSEP, and kbile were estimated by non-linear least squares minimization using in-house made software (www.liver.dk/ifit.html) using C liver (t) as output, C in (t) as input and V blood set to 0.2 mL blood/mL liver tissue. C bile (t) was measured in experiments with CHD catheter but was not used to estimate the model parameters.
Hepatic systemic clearance of 11 C-CSar, K sys (mL blood/mL liver tissue/min), was calculated as (20)
In some cases, the analysis yielded K mem values higher than Q, an innate problem with Figure 2 shows examples of the time courses of 11 C-CSar concentrations in blood, liver tissue and bile in experiments without and with a catheter in CHD. In all experiments, C in (t) and C out (t) became constant after 10-20 minutes. C liver (t) increased rapidly in all experiments but in experiments with CHD catheter, steady levels of C liver (t) were only reached in half of the experiments whereas steady levels were reached within 20 minutes in two thirds of the experiments without a catheter. These findings are in agreement with a cholestatic effect caused by the CHD catheter that primarily affected hepatocyte secretion of 11 C-CSar into bile, not uptake from blood. Interestingly, C bile (t) had the same shape as the corresponding C liver (t), but the concentration in bile was on average 200 times higher (Fig. 2C) .
RESULTS
In Table 1 , values of the kinetic parameters estimated from PET data are shown. Mean k BSEP was many times higher than mean k backflux which illustrates that secretion from hepatocytes into bile was much more efficient and physiologically significant than the backflux. The CHD catheter caused a significant decrease in both k BSEP and K int , an insignificant decrease in k bile and a significant increase in k backflux . These data point to a minor cholestatic effect of the CHD catheter (reduced k bile ) that led to reduced secretion from hepatocytes into bile (k BSEP ) which in turn led to increased backflux of 11 C-CSar from hepatocytes to blood (k backflux ). In accordance with these findings, K int , was significantly higher in experiments without CHD catheter than in experiments with a catheter. K sys was unaffected by the CHD catheter which can be explained by an increase in Q (see below) since K sys is flow-determined.
Mean steady state C bile was 22,000 kBq/mL bile (range, 8,000-38,000 kBq/mL bile) which was on average 4,000 times (range, 2,400-4,700 times) higher than the corresponding C in .
Mean measured F bile was 0.27 mL bile/min (95% CI 0.21-0.33 mL bile/min). The fractional intrahepatic bile volume, V bile , was on average 2.1 mL bile/L liver tissue (range, 1.21-7.52 mL bile/L liver tissue). In studies without CHD catheter, calculated F bile was on average 0.45 mL bile/min (range, 0.37-0.52 mL bile/min) (P < 0.05 when compared to measured values in experiments with catheter).
In Table 2 , values of hepatic blood perfusion and kinetic parameters of hepatic uptake from blood and biliary secretion of 11 C-CSar calculated from blood measurements are shown.
Interestingly, Q was on average 25% higher in experiments with CHD catheter than in experiments without a catheter (P < 0.05) which was caused by an increase in the portal vein blood flow with no change in hepatic arterial flow.
by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from E 0 was lower in experiments with CHD catheter than in experiments without catheter but still close to unity which indicates a high unidirectional transport of 11 C-CSar from blood to hepatocytes in both groups of animals. Since E 0 is flow-dependent, the small but statistically significant difference between E 0 in the two groups of animals can be explained by the difference in Q (22,23), an explanation confirmed by the unaffected flow-independent PS mem values. The transport capacity across the hepatocyte sinusoidal membrane of 11 C-CSar was accordingly unaffected by the CHD catheter.
The capacity for the overall transport of 11 C-CSar from blood into bile, as quantified by the intrinsic clearance Cl int (Table 2) , was significantly lower in pigs with CHD catheter than in pigs without a catheter (P < 0.001). Furthermore, E ss was significantly lower than E 0 in pigs with CHD catheter (P < 0.05) whereas it was not statistically different from E 0 in experiments without a catheter ( Table 2 ). This shows that the reduced secretion of 11 C-CSar in experiments with CHD catheter caused an increased backflux of 11 C-CSar from hepatocytes to blood as also seen in the PET parameters.
The correlation between Cl sys from blood data and K sys from PET data as well as the correlation between Cl int and K int were both excellent (r 2 = 0.7, P < 0.05).
DISCUSSION
The main result from the present study is that it is now possible to quantify the individual steps in hepatic uptake and biliary secretion of conjugated bile acids in vivo using dynamic 11 C-CSar PET. The method was even able to quantify changes in kinetic parameters caused by the acute albeit mild cholestasis induced by the CHD catheter. The finding that steady state secretion rate of 11 C-CSar was equal to the removal rate from blood ( Figure 3) shows that the hepatocytes did not accumulate 11 C-CSar during the infusion of 11 C-CSar but simply facilitated transport of bile acids from blood into bile against a measured concentration gradient of 4,000 from blood to bile.
Steady state extraction fraction of 11 C-CSar from blood, E ss , was lower than E 0 in experiments with CHD catheter but not in experiments without catheter. The cholestatic effect of the catheter thus increased backflux of bile acids from hepatocytes to blood which was not measurable from blood data under normal conditions but measurable by PET in all experiments. From in vitro studies, it is known that the hepatocytes have transporters (MRP3/4 and OSTα/β) for efflux of bile acids into blood which can be induced during cholestasis (25,26). Backflux is thus an innate ability of hepatocytes and using 11 C-CSar PET, we demonstrated backflux even in the normal state, not just during cholestasis. Since the hepatic blood perfusion was constant throughout each PET recording, the E ss /E 0 ratio is equal to k BSEP /(k backflux +k BSEP ) (22). From this relation it is seen that the physiological significance of backflux is relative to the canalicular secretion and that a decrease in k BSEP can cause an apparent increase in k backflux (22). By using dynamic 11 C-CSar PET, we could show that k backflux in acute cholestasis is in fact increased, not only relative to k BSEP , but on average 20-fold compared to k backflux in pigs without CHD catheter. This separation between the individual impact of k backflux and k BSEP on E ss cannot be done from blood measurements alone.
Another interesting finding is that the CHD catheter caused a significant increase in the hepatic blood perfusion by a selective increase in the portal vein blood flow. Since the hepatic systemic clearance of 11 C-CSar is flow-determined, this may serve as a regulatory mechanism to secure a high clearance of conjugated bile acids in spite of impaired BSEP, a theory supported by the finding of similar values of hepatic systemic clearance estimated from blood data (Cl sys ) and PET data (K sys ) in both groups of animals. However, the present data do not allow us to draw any conclusions on the potential mechanism behind this finding.
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Since there was no accumulation of 11 C-CSar in the hepatocytes, the highest possible intrahepatic bile volume was estimated as C liver /C bile which yielded a mean maximum volume of 6.0 mL bile/L liver tissue (95% CI, 5.8-6.3 mL bile/L liver tissue) which, together with a mean 3.2 mL bile/L liver tissue in stereology studies of human biopsies (27), support the validity of present mean fractional intrahepatic bile volume of 2.1 mL bile/L liver tissue estimated from the PET data (Eq. 11).
There was no significant difference between steady state C HA (t) and C PV (t) (mean difference 3%, range from -19 to 31%; P > 0.30) which shows that there was no loss of 11 C-CSar in the prehepatic splanchnic bed. This is important for future human studies, where it is not possible to obtain blood samples from the portal vein. C PV (t) can then be calculated by using a model of the transfer of tracer from that measured in an artery to the portal vein by means of a transfer time constant, β (28, 29) , which in the present study was on average 13 sec (95% CI, Clinical application of PET studies with radio-labeled bile acids is likely to include clinical evaluation of patients with cholestatic disorders that affect bile acid uptake, secretion, and/or bile flow and for evaluation of disease progression or treatment efficacy. The method can also be used to examine how pharmaceuticals may affect hepatobiliary excretory functions.
CONCLUSION
Functional 11 C-CSar PET was successful for quantification of in vivo kinetics of hepatobiliary secretion of conjugated bile acids by external detection in pigs. Relationship between steady state hepatic removal rate of 11 C-CSar, v ss , calculated from blood measurements (Eq. 7) and directly measured secretion from bile sampling, v bile (Eq. 10) in experiments with catheter in the common hepatic duct. Line of identity is shown. Repeated measurements in the same pig have identical symbols. by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from 
